Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
16/06/2026 13:46
BUZZ-Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device ** Shares of Medical device maker Microbot Medical MBOT.O rise 4% to $1.87 premarket
** Co signs deal with Lovell Government Services to supply Liberty, a robotic device for minimally invasive blood vessel procedures
** Says Liberty is a single-use, remotely operated system that helps doctors perform vascular procedures with more precision
** Co says deal opens access to U.S. federal healthcare systems including veterans, military and Native American hospitals
** Says device expected to be available via federal supply contracts in Q3 2026
** Says partnership aims to improve adoption and streamline sales through government platforms
** As of last close, stock down ~9% YTD
(Reporting by Sahil Pandey in Bengaluru)
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones